Skip to content
Research Article Open access CC BY 4.0

Transmission, Stability, Symptoms, Diagnosis and Management of COVID 19

P. G. I. Dias, R. M. U. S. K. Rathnayaka

Asian Journal of Research in Infectious Diseases · pp. 39–47 · Published 17 Jun 2020

10.9734/ajrid/2020/v4i130140

Abstract

COVID 19 can be considered as the most devastating pandemics that happened in the 21st century. Many researches on its virology, epidemiology, transmission, diagnosis, and treatments are ongoing. Studies on the causative virus of COVID 19 has been successfully carried out. Its genome has been sequenced, analyzed and compared with other corona viruses in those studies. Some studies on disease transmission also been carried out and as an outcome of those studies, information about the stability of the virus in different conditions and sources of disease transmission are available. Symptoms of the disease also been successfully identified and diagnosis methods to identify infected patients are also been developed. Preventive measures for the disease also been published and implemented in many countries. However, at the time of writing, there is no permanent cure for this viral infection and it would take time to develop a vaccine and/or other medicine for this disease.

COVID 19 corona virus symptoms diagnosis

References (45)

  1. 1 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [DOI]
  2. 2 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [DOI]
  3. 3 Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro [DOI]
  4. 4 The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak [DOI]
  5. 5 The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status [DOI]
  6. 6 Temporal dynamics in viral shedding and transmissibility of COVID-19 [DOI]
  7. 7 Features, Evaluation and Treatment Coronavirus (COVID-19)
  8. 8 Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies [DOI]
  9. 9 Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan [DOI]
  10. 10 Air pollution and COVID-19 mortality in the United States: Strengths and limitations of an ecological regression analysis [DOI]
  11. 11 Stability of SARS-CoV-2 in different environmental conditions [DOI]
  12. 12 Airborne transmission of SARS-CoV-2: The world should face the reality [DOI]
  13. 13 Viral dynamics in mild and severe cases of COVID-19 [DOI]
  14. 14 Real-time tracking of self-reported symptoms to predict potential COVID-19 [DOI]
  15. 15 The SARS-CoV-2 outbreak: What we know [DOI]
  16. 16 COVID-19 and smoking: A systematic review of the evidence [DOI]
  17. 17 A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19 [DOI]
  18. 18 Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies [DOI]
  19. 19 COVID-19, SARS and MERS: are they closely related? [DOI]
  20. 20 Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 2020 [DOI]
  21. 21 Convalescent plasma as a potential therapy for COVID-19 [DOI]
  22. 22 Can atmospheric pollution be considered a co-factor in extremely high level of SARS-CoV-2 lethality in Northern Italy? [DOI]
  23. 23 Pathogenicity and transmissibility of 2019-nCoV—A quick overview and comparison with other emerging viruses [DOI]
  24. 24 Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes [DOI]
  25. 25 Ethnicity and COVID-19: an urgent public health research priority [DOI]
  26. 26 Clinical features of covid-19 [DOI]
  27. 27 Could BCG be used to protect against COVID-19? [DOI]
  28. 28 A close-up on COVID-19 and cardiovascular diseases [DOI]
  29. 29 Social Distancing in the Covid-19 Pandemic [DOI]
  30. 30 Treatment of severe pneumonia due to COVID-19 with peginterferon alfa 2a [DOI]
  31. 31 US drug companies pledge to keep price rises “reasonable” as legislators try to rein in costs [DOI]
  32. 32 The American Journal of Gastroenterology [DOI]
  33. 33 COVID-19: Gastrointestinal Manifestations and Potential Fecal–Oral Transmission [DOI]
  34. 34 Real-time RT-PCR in COVID-19 detection: issues affecting the results [DOI]
  35. 35 International Journal of Science and Research (IJSR) [DOI]
  36. 36 Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: A Retrospective Case Series Study [DOI]
  37. 37 High Temperature and High Humidity Reduce the Transmission of COVID-19 [DOI]
  38. 38 Correlation between universal BCG vaccination policy and reduced mortality for COVID-19 [DOI]
  39. 39 Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (Coronaviridae) [DOI]
  40. 40 Remdesivir as a possible therapeutic option for the COVID-19 [DOI]
  41. 41 Severe Acute Respiratory Syndrome [DOI]
  42. 42 COVID-19 (Coronavirus Disease-19): Traditional Chinese Medicine including Acupuncture for Alleviation – A Report from Wuhan, Hubei Province in China [DOI]
  43. 43 Plants as a Prospective Source of Natural Anti-viral Compounds and Oral Vaccines Against COVID-19 Coronavirus [DOI]
  44. 44 Environmental Concern Regarding the Effect of Humidity and Temperature on SARS-COV-2 (COVID-19) Survival: Fact or Fiction [DOI]
  45. 45 OBM Integrative and Complementary Medicine [DOI]

Cited by 4

Inclusive Review on Existing Treatment and Management Modalities for COVID-19

Jalpa Suthar, Jhanvi Patel · COVID-19 Drug Development - Recent Advances, New Perspectives and Applications · 2022

Stability analysis of COVID-19 model with fractional-order derivative and a delay in implementing the quarantine strategy

M. M. Hikal, M. M. A. Elsheikh, W. K. Zahra · Journal of Applied Mathematics and Computing · 2021

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

79

Page views

0

PDF downloads

50

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.